Table 4.
The Clinical Outcomes in Patients with LAAO Within 5-Years Follow-Up
| Events | Total (n=107) | |
|---|---|---|
| Mean follow-up time (months) | 42.7±16.8 | |
| 1. MACEs | ||
| Cardiovascular mortality | 3.7% (4) | |
| Heart Failure | 23.4% (25) | |
| Stroke/systemic embolism | 10.3% (11) | |
| Systemic embolism | 10.3% (11) | |
| 2. Secondary endpoints | ||
| Puncture site complications | 6.5% (7) | |
| All-cause mortality | 7.5% (8) | |
| Pericardial effusion | 1-year | 13.1% (14) |
| 2-year | 7.5% (8) | |
| 3-year | 5.6% (6) | |
| Bleeding | 6.5% (7) | |
Abbreviations: LAAO, left atrial appendage occlusion; MACE, major adverse cardiovascular events.